Karyopharm and Promedico, a Member of the Neopharm Group, Enter into an Exclusive Distribution Agreement to Commercialize XPOVIO® (Selinexor) in Israel

Karyopharm is also eligible to receive double-digit royalties on future net sales of XPOVIO in the covered territory.